Literature DB >> 3278956

Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases.

D A Daya1, R E Scully.   

Abstract

Although the clinical and pathological features of sarcoma botryoides of the vagina in infancy are well documented in the literature, only occasional cases of a histologically similar tumor of the uterine cervix have been described, mostly as individual case reports. We have reviewed 13 cases of sarcoma botryoides of the cervix. The patients range in age from 12 to 26 years, with a mean of 18 years. All presented with vaginal bleeding, "something" protruding from the introitus, or both. On gross examination the tumors were polypoid, smooth, glistening, and focally hemorrhagic. Microscopic examination revealed the presence of a cambium layer and cells showing the features of rhabdomyoblasts in all the cases. Six of the 13 tumors (45%) contained foci of mature cartilage. All the patients were alive and well 1 to 8 years (average 3.5 years) postoperatively except for one who died of the tumor after 1 year. Although most of the patients had a radical operation, sometimes followed by chemotherapy, three had excellent results after polypectomy or cervicectomy. The findings indicate that, unlike its counterpart in the vagina, which has a poor prognosis, sarcoma botryoides of the cervix in young women has a favorable outlook.

Entities:  

Mesh:

Year:  1988        PMID: 3278956     DOI: 10.1016/0090-8258(88)90228-4

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  25 in total

1.  Sarcoma botryoides (embryonal rhabdomyosarcoma) of the uterine cervix in sisters.

Authors:  Azamsadat Mousavi; Setare Akhavan
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

2.  Embryonal rhabdomyosarcoma of the cervix with focal pleomorphic areas.

Authors:  J P Houghton; W G McCluggage
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

3.  Rhabdomyosarcoma of the cervix in adult women and younger patients.

Authors:  Maya L Kriseman; Wei-Lien Wang; Jana Sullinger; Kathleen M Schmeler; Pedro T Ramirez; Cynthia E Herzog; Michael Frumovitz
Journal:  Gynecol Oncol       Date:  2012-05-15       Impact factor: 5.482

4.  Cytogenetic study of botryoid rhabdomyosarcoma of the uterine cervix.

Authors:  J P Palazzo; Z Gibas; C J Dunton; A Talerman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 5.  A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus.

Authors:  W Glenn McCluggage
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

6.  Botryoid Rhabdomyosarcoma of the Cervix: Case report with review of the literature.

Authors:  Bajpai Neha; Attibele P Manjunath; Shivarudraiah Girija; Kumar Pratap
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

7.  18-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi.

Authors:  O Strahl; A Hartmann; F C Thiel; M W Beckmann; M P Lux
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-12       Impact factor: 2.915

8.  Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.

Authors:  Louis P Dehner; Jason A Jarzembowski; D Ashley Hill
Journal:  Mod Pathol       Date:  2011-12-09       Impact factor: 7.842

Review 9.  Embryonal rhabdomyosarcoma of the uterine cervix.

Authors:  Georgios V Koukourakis; Vassilios Kouloulias; Georgios Zacharias; Georgios Maravelis; Christos Papadimitriou; Kaliopi Platoni; Athanasios Gouliamos
Journal:  Clin Transl Oncol       Date:  2009-06       Impact factor: 3.405

10.  Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical hysterectomy.

Authors:  Mark L Kayton; Leonard H Wexler; Sharyn N Lewin; Kay J Park; Michael P La Quaglia; Nadeem R Abu-Rustum
Journal:  J Pediatr Surg       Date:  2009-04       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.